09.10.03 - Maryland Racing Commission - Final Regulations
FINAL ACTION ON REGULATIONS
MARYLAND REGISTER, VOLUME 43, ISSUE 25,
FRIDAY, DECEMBER 9, 2016
Subtitle 10 RACING COMMISSION
09.10.03 Prohibited Acts
Business Regulation Article, §11-210, Annotated Code of Maryland
Notice of Final Action
On November 15, 2016, the Maryland Racing Commission adopted amendments to Regulation .01 under COMAR 09.10.03 Prohibited Acts. This action, which was proposed for adoption in 43:20 Md. R. 1113 (September 30, 2016), has been adopted as proposed.
Effective Date: December 19, 2016.
J. MICHAEL HOPKINS
A. In this chapter, the following terms have the meanings indicated:
B. Terms Defined.
(a) (text unchanged)
(b) “Drug” includes [the] any combination of phenybutazone,[and] flunixin, or ketoprofen if:
(i) Phenylbutazone is quantitated at more than 0.3 micrograms per milliliter of blood plasma or serum; [and]
(ii) Flunixin is quantitated at more than 3.0 nanograms per milliliter of blood plasma or serum; and
(iii) Ketoprofen is quantitated at more than 1.0 nanogram per milliliter of blood plasma or serum.
(2) — (3) (text unchanged)